This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...